> ## Content Index
> Fetch the complete content index at: https://newsletters.qs.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# 💊 Health Futures #34
- URL: https://newsletters.qs.com/health-futures-33-copy/
- Published: 2024-09-09T11:30:31.000Z
- Updated: 2024-09-09T11:30:33.000Z
- Description: HolonIQ's Health Newsletter covers the latest developments in AI in health, biotech clinical trials, and digital health and highlights the week's top health deals.
- Author: QS
- Tags: Health Skills

**Happy Monday 👋**   
  
This week's health news highlights advancements in digital health, biotechnology clinical trials, and AI in healthcare. The latest digital health news, Kyriba [partnered](https://erp.today/prescribing-liquidity-and-treasury-management-for-the-healthcare-industry/?ref=newsletters.qs.com) with Saudi German Health (SGH). Kyriba's solutions will automate key treasury processes, enhance accuracy, and provide real-time visibility into liquidity positions. In Biotechnology, Sanofi's Tolebrutinib [missed](https://health.economictimes.indiatimes.com/news/pharma/pharma-industry/sanofis-mixed-fortunes-in-ms-drug-trials-has-market-focus-on-win/112996072?ref=newsletters.qs.com) the primary endpoint in two Phase III trials in which the drug candidate slowed disability progression in patients with MS compared to a placebo. For AI in health this week, Google[ introduced](https://health.economictimes.indiatimes.com/news/health-it/google-working-on-ai-that-can-detect-tb-through-the-sound-of-cough-and-breathing/112941137?ref=newsletters.qs.com) a significant AI system that potentially detects early signs of disease by analyzing audio signals. In terms of health funding, Spring Health secured a[ $100M](https://thehealthcaretechnologyreport.com/spring-health-secures-100-million-series-e-funding-at-3-3-billion-valuation/?ref=newsletters.qs.com) Series E funding round, increasing its valuation to $3.3B..

## 💉 Digital Health

  
🖥️ **Kyriba** [**partnered**](https://erp.today/prescribing-liquidity-and-treasury-management-for-the-healthcare-industry/?ref=newsletters.qs.com) **with Saudi German Health (SGH) to provide advanced treasury solutions.** SGH will use Kyriba’s platform to automate key treasury processes, enhance accuracy, and improve financial visibility aiming to offer a new standard for treasury management in the healthcare industry.

✨ **ST Engineering and Royal Philips partnered to offer complementary digital health solutions.** The[partnership](https://www.stengg.com/en/newsroom/news-releases/st-engineering-and-philips-collaborate-to-provide-digital-health-solutions?ref=newsletters.qs.com) aimed for bedside support and capacity management combining ST Engineering's operations command center, robotics, and AI-enabled applications with Philips' clinical command center.

🧠 **Birmingham and Solihull ICB launched digital social prescribing.** This [launch](https://www.digitalhealth.net/2024/09/birmingham-and-solihull-icb-launches-digital-social-prescribing/?ref=newsletters.qs.com) helps to meet the growing demand for mental health support. Social prescribing is an approach that connects people's social and emotional needs to their well-being.

## 🧬 BioTech Clinical Trials  

🫀**Abbott's heart clip**[ **showed**](https://www.fiercebiotech.com/medtech/esc-abbott-mitraclip-study-shows-gains-functional-yet-leaky-heart-valves?ref=newsletters.qs.com) **partial success in the trial.** The MitraClip device for treating failure reduced hospitalization and improved health status in patients but it failed to lower the death rates. 

🔬 **Bayer's Kerendia reduced the risk of cardio death.** The pharmaceutical company [revealed ](https://www.fiercepharma.com/pharma/bayers-kerendia-reduced-risk-cardio-death-16-tough-treat-class-heart-failure-patients?ref=newsletters.qs.com)from the phase 3 trial that the Kerendia drug reduced the risk of cardiovascular death in patients with certain types of heart failure.

💉 **Sanofi's** [**mixed**](https://health.economictimes.indiatimes.com/news/pharma/pharma-industry/sanofis-mixed-fortunes-in-ms-drug-trials-has-market-focus-on-win/112996072?ref=newsletters.qs.com) **results in Multiple Sclerosis drug trials.** Sanofi has missed the primary goal of drug candidates of two clinical trials to treat relapsing forms of the disease. Still, on the positive side, a less common form of progressive MS (multiple sclerosis) succeeded.

##  💻 AI in Health  

🏥 **Neko Health**[ **opens**](https://techcrunch.com/2024/09/03/neko-health-the-body-scanning-ai-health-startup-from-spotifys-daniel-ek-opens-in-london/?ref=newsletters.qs.com) **in London.** The founder of Spotify uses AI body-scanning technology for preventive health purposes that can detect conditions like heart disease and skin cancer. 

🤖 **Aidoc** [**secured** ](https://www.medicaldevice-network.com/news/aidoc-gains-ce-mark-for-new-ai-radiology-algorithms/?ref=newsletters.qs.com)**the CE marking of four new AI algorithms.** The algorithm strengthens the ability of the aiOS platform for healthcare providers in Europe.

**🔊 Google** [**introduced**](https://health.economictimes.indiatimes.com/news/health-it/google-working-on-ai-that-can-detect-tb-through-the-sound-of-cough-and-breathing/112941137?ref=newsletters.qs.com) **a groundbreaking AI system.** The AI model can detect tuberculosis through the sound of coughs and breathing patterns.The algorithm is trained with 300M audio samples including coughs, sniffles, and breathing patterns, and aims to identify diseases like tuberculosis (TB).

## **💰** Deals of the Week  

🍃 **Spring Health**, a mental health benefits provider, secured a[ $100M](https://thehealthcaretechnologyreport.com/spring-health-secures-100-million-series-e-funding-at-3-3-billion-valuation/?ref=newsletters.qs.com) Series E funding round, which has increased the company's valuation to $3.3B. 

**📱 Samsung Medison**, an affiliation of Samsung Electronics, acquired **Sonio** for [$96M](https://femtechinsider.com/samsung-medison-finalizes-acquisition-of-french-fetal-ultrasound-ai-software-company-sonio/?ref=newsletters.qs.com) following the approval of the French Ministry of the Economy and Finance. 

🧫 **Circle Pharma**, a CA-based clinical-stage company, raised [$90M](https://www.finsmes.com/2024/09/circle-pharma-closes-90m-series-d-financing.html?ref=newsletters.qs.com#google%5Fvignette) in Series D funding intending to fund the clinical development of CID-078 (cyclin A/B RxL inhibitor).

👩‍⚕️ **Doccla**, a provider of virtual ward and remote patient monitoring services, raised a funding of [$38.6M](https://www.mobihealthnews.com/news/doccla-raises-more-38m-increase-european-expansion?ref=newsletters.qs.com) Series B funding round for expanding in Europe.

💵 **Vesta Healthcare** secured a [$35M](https://www.finsmes.com/2024/09/vesta-healthcare-receives-35m-loan-facility-from-horizon-technology-finance.html?ref=newsletters.qs.com) venture loan facility from **Horizon Technology Finance**. Initially, a $25M portion has been funded. The loan is utilized for growth and working capital purposes.

---

**Thank you for reading. Have a great week ahead!**  
Have some feedback or suggestions? Let us know at hello@holoniq.com

[ ](https://newsletters.qs.com/psychedelic-mental-health-treatments-south-asia-health-tech-100-2/)